B
EDIT icon

Bailard’s Editas Medicine EDIT Stock Holding History

Bailard’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-33,875
Closed -$118K – 784
2025
Q3 		$118K Hold
33,875
– – ﹤0.01% 759
2025
Q2 		$74.5K Hold
33,875
– – ﹤0.01% 747
2025
Q1 		$39.3K Hold
33,875
– – ﹤0.01% 734
2024
Q4 		$43K Hold
33,875
– – ﹤0.01% 725
2024
Q3 		$116K Hold
33,875
– – ﹤0.01% 727
2024
Q2 		$158K Hold
33,875
– – ﹤0.01% 696
2024
Q1 		$251K Buy
+33,875
New +$281K 0.01% 624
2021
Q3 		– Sell
-10,000
Closed -$566K – 724
2021
Q2 		$566K Buy
+10,000
New +$369K 0.02% 386

Other funds holding EDIT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return